Results 141–160 of 2338 for speaker:the Countess of Mar

Air Guns - Question ( 5 Mar 2018)

the Countess of Mar: My Lords, what is the age range of offenders when they are caught? If they are youngsters, as I suspect, would it not be a good idea if parents, who often buy these things as presents for their teenagers, are advised that the present should be accompanied by lessons?

National Child Obesity Strategy - Question (26 Feb 2018)

the Countess of Mar: My Lords, does the Minister consider that there is an elephant in the room? There are thousands of endocrine-disrupting chemicals that children and young people have been exposed to since they were in the womb. Nobody seems to be looking at the effects of endocrine disruptors on appetite and obesity.

Medicines and Medical Devices Safety Review - Statement (22 Feb 2018)

the Countess of Mar: My Lords, I am very grateful to the Minister for repeating the Statement but I put on the record my severe reservations about the safety of HPV vaccines. The noble Lord knows of my concern. I have had meetings with the MHRA but it seems to think that mañana is quite rapid enough to be dealing with it. The situation he described for those patients dealt with in the Statement is exactly the...

Written Answers — Ministry of Defence: Armed Forces: Mefloquine (30 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government whether the Surgeon General of Her Majesty’s Armed Forces recognises the chronic neurotoxic effects on members of the Armed Forces and Veterans from the administration of mefloquine (Lariam); and whether they will be addressing the problems caused by those effects in the near future.

Written Answers — Ministry of Defence: Armed Forces: Mefloquine (30 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government whether they intend that an addendum should be added to the Defence Mental Health and Wellbeing Strategy Report 2017–2022 in order to address the effects of neurotoxicity from mefloquine; if so, when it will be published; and if not, why not.

Written Answers — Department of Health and Social Care: Medical Records (25 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government what remedy there is when a hospital trust persistently refuses to release full medical records to a patient or a GP for the patient under the Access to Medical Records Act 1990 and the Data Protection Act 1998 and may have destroyed some of those records despite their being protected on police advice.

Written Answers — Department for Education: Mental Health Services: Schools (25 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government whether teachers who become Designated Senior Leads for Mental Health to oversee the approach to mental health and wellbeing in schools will be trained to distinguish children with anxiety, depression or behavioural problems from children who have myalgic encephalomyelitis (chronic fatigue syndrome) as a primary cause of their illness.

Written Answers — Department for Environment, Food and Rural Affairs: Glyphosate (22 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government what assessment they have made of the findings of Defarge et al in Toxicity of formulants and heavy metals in glyphosate-based herbicides and other pesticides published in Toxicology Reports, volume 5, about the use of so-called inert ingredients in those chemical formulations.

Written Answers — Department of Health: Mefloquine (18 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 22 December 2017 (HL4314), whether they consider suicide, as listed in the current mefloquine product information as a psychiatric adverse reaction, to be a permanent adverse reaction.

Written Answers — Department for Business, Energy and Industrial Strategy: Furniture: Fire Resistant Materials (17 Jan 2018)

the Countess of Mar: To ask Her Majesty's Government what assessment they have made of the findings of Professor Richard Hull, published in Chemosphere, that the application of flame retardants "makes furniture burn more quickly, reaching higher temperatures and producing vastly more toxic smoke" when tested in real life environments; and whether they intend to promote the use of flame retardant-free materials.

Written Answers — Department for Education: Pupils: Attendance (22 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government, further to the Written Answer by Lord Agnew of Oulton on 6 December (HL3501), whether the Department for Education would normally expect to be made aware of any research concerning school attendance which involved the divulgence of names and addresses of school pupils by school attendance officers.

Written Answers — Department of Health: Mefloquine (22 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 19 December (HL3942), whether they consider (1) suicide, and (2) the “irreversible” neurological condition described in the current mefloquine product information to be permanent adverse reactions.

Written Answers — Department of Health: Autism (21 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government whether they have made an assessment of the findings of Matthew Mold et al on aluminium in brain tissue in autism, reported in the Journal of Trace Elements in Medicine and Biology; and if so, whether they will encourage further investigation of the link between the incidence of autism spectrum disorder and aluminium.

Written Answers — Department of Health: Human Papillomavirus: Vaccination (20 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 5 December (HL3500), whether they will place a copy of the systematic review of serious adverse reactions following HPV vaccines, commissioned by the World Health Organisation, in the Library of the House.

Written Answers — Department of Health: Mefloquine (19 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government, further to the Written Answers by Lord O'Shaughnessy on 5 December (HL3532) and 27 November (HL3227), whether they have seen the unclassified order of the US Surgeon General’s Office of the Army Special Command of 13 September 2013; whether there is any difference between the drug of the same name administered to US troops and that issued to British troops;...

Written Answers — Department for Environment, Food and Rural Affairs: Brofiscin Quarry (11 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government what assessment they have made of whether capping the limestone quarry at Brofiscin has prevented non-biodegradable PCBs and other toxic materials from leaching into the underlying aquifer affecting water supplies in England.

Written Answers — Department for Environment, Food and Rural Affairs: Brofiscin Quarry (11 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government what assessment they have made of whether or not the water supplies for Birmingham contain residues of non-biodegradable PCBs and other toxins as a result of leaching from Brofiscin quarry.

Written Answers — Department for Education: Pupils: Chronic Fatigue Syndrome ( 6 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government whether parental consent was obtained by school attendance officers before parents were sent letters by researchers for the study entitled Unidentified Chronic Fatigue Syndrome/myalgic encephalomyelitis is a major cause of school absence: surveillance outcomes from school-based clinics, published by the British Medical Journal in 2011.

Written Answers — Department of Health: Human Papillomavirus: Vaccination ( 5 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government whether they intend to place a copy of the systematic review of serious adverse reactions following HPV vaccines, commissioned by the World Health Organisation, in the Library of the House.

Written Answers — Department of Health: Armed Forces: Mefloquine ( 5 Dec 2017)

the Countess of Mar: To ask Her Majesty's Government, further to the Written Answer by Earl Howe on 22 November (HL3229), what assessment they have made of the conclusions of the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency in 2014 that: “There is enough evidence … supporting a causal relationship between mefloquine and the occurrence of long lasting and even persistent...


<< < 1 2 3 4 5 6 7 8 9 10 > >>

Create an alert

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.